000 01513 a2200409 4500
005 20250515083616.0
264 0 _c20080304
008 200803s 0 0 eng d
022 _a1460-2180
024 7 _a10.1093/carcin/bgm201
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPérez-Durán, Pablo
245 0 0 _aOncogenic events triggered by AID, the adverse effect of antibody diversification.
_h[electronic resource]
260 _bCarcinogenesis
_cDec 2007
300 _a2427-33 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies
_ximmunology
650 0 4 _aB-Lymphocytes
_ximmunology
650 0 4 _aCell Transformation, Neoplastic
650 0 4 _aChromosome Aberrations
650 0 4 _aCytidine Deaminase
_xbiosynthesis
650 0 4 _aGene Rearrangement
650 0 4 _aGenes, Immunoglobulin
_ximmunology
650 0 4 _aGerminal Center
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Class Switching
650 0 4 _aLymphoma, B-Cell
_ximmunology
650 0 4 _aRecombination, Genetic
650 0 4 _aSomatic Hypermutation, Immunoglobulin
650 0 4 _aTumor Suppressor Proteins
_xphysiology
650 0 4 _aAICDA (Activation-Induced Cytidine Deaminase)
700 1 _ade Yebenes, Virginia G
700 1 _aRamiro, Almudena R
773 0 _tCarcinogenesis
_gvol. 28
_gno. 12
_gp. 2427-33
856 4 0 _uhttps://doi.org/10.1093/carcin/bgm201
_zAvailable from publisher's website
999 _c17333115
_d17333115